A Tumor Lysis Syndrome Risk Assessment and Its Impact on Patients

Web Exclusives
The Lynx Group: 2021 Ask The Expert MDietrich.pdf
Please Click the Issue to Download


In an interview, Nicholas Short, MD, shares objectives on the design and benefits of MD Anderson’s Tumor Lysis Syndrome clinical assessment for patient risk and impact on patient care.

Download to Continue Reading

Sponsored by

Subscribe Today!

To sign up for our newsletter or print publications, please enter your contact information below.

I'd like to receive: